---
pmcid: PMC10002683
image_filename: nihpp-2023.02.28.530478v1-f0003.jpg
figure_link: /pmc/articles/PMC10002683/figure/F3/
number: Figure 3
figure_title: ''
caption: 'Critical metabolites required for methionine cycle, GSH biosynthesis and
  TSP in patients with CRC. A: Male: KRAS mutant CRCs (n=25), KRAS wild type CRCs
  (n=58), normal colon tissues (n=27); B: Female: KRAS mutant CRCS (n=35), KRAS wild
  type CRCs (n=43), normal colon tissues (n=12). Kruskalâ€“Wallis rank sum test with
  Wilcoxon Mann-Whitney U test, p-values adjusted for false discovery rates (FDR)
  (Benjamini-Hochberg). *p < 0.05, **p < 0.01, ***p < 0.001, NS. = not significant.Abbreviations:
  GSH: reduced glutathione, GSSG: oxidized glutathione, SAM, S-Adenosylmethionine;
  SAH, S-Adenosylhomocysteine; TSP, transsulfuration pathway'
article_title: Discovery of decreased ferroptosis in male colorectal cancer patients
  with KRAS mutations.
citation: Hong Yan, et al. bioRxiv. 2023 Mar 1:2023.02.28.530478.

doi: 10.1101/2023.02.28.530478
journal_title: bioRxiv
journal_nlm_ta: bioRxiv
publisher_name: Cold Spring Harbor Laboratory

keywords:
- KRAS
- colorectal cancer
- ferroptosis
- sex-specific differences
- metabolomics

---
